Puma Biotechnology (Nasdaq:PBYI) - Stock Price, News & Analysis - Simply Wall St
Puma Biotechnology to Move Stock Exchange Listing to Nasdaq | Business Wire
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
PBYI Insider Trading Activity - Puma Biotechnology, Inc.
The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech (NYSE: PBYI) Stock Skyrockets 300% on Breast Cancer Breakthrough
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma shares nearly triple on drug news, but options smell 'fishy'
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
Former Puma Biotech executive gets U.S. prison term for insider trading
Puma Biotechnology: Waiting For Commercial Numbers To Catch Up To Clinical Data (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Puma Biotechnology (NASDAQ:PBYI) Stock Price News
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotechnology
Puma Biotechnology Inc Share Price USD0.0001
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotechnology (NASDAQ:PBYI) Stock Price News
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
What Happened To Puma Biotechnology?
PUMA BIOTECHNOLOGY, INC.
Puma Biotechnology falls more than 20%
